Inquire Before Buying - Flow Cytometry In Oncology Market Growth and Demand Through 2026

Global Flow Cytometry in Oncology Market Research Report: Forecast (2021-2026)

By Type (Assay & Kits, Instruments, Reagents & Consumables, Software), By Technology (Cell Based, Bead Based), By Type of Cancer (Hematological Malignancies (Lymphoma, Leukemia, My......eloma), Solid Tumors (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer)), By Application (Translational Research, Clinical Applications (Screening & Diagnostics, Treatment Monitoring)), By End User (Diagnostic Laboratories, Hospitals & Healthcare Centers, Academic & Research Institutes), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (The US, Canada, Mexico, Brazil, The UK, Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, India, China, Japan, South Korea), By Company (Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cytognos, S.L., Danaher Corporation, Luminex Corporation, Sony Corporation, Cytek Biosciences) Read more

Healthcare
Oct 2021
Pages 221
Report Format: PDF, Excel, PPT

Market Definition

Flow Cytometry is a laboratory method that helps measure the percentage of live cells and the number of cells & their characteristics of cells like shape & size, using a sample of bone marrow, blood, or any other tissue. Cells are stained with a light-sensitive dye, suspended in a fluid, and then passed through a beam of light, to which the stained cells react and generate the results. This process is used in research and helps diagnose certain diseases, including cancer.

Market Insights

The Global Flow Cytometry in Oncology Market is anticipated to grow at a CAGR of around 11.2% during the forecast period, i.e., 2021-26. Flow cytometry has evolved for a long time from a niche laboratory technique to a routine method used by immunologists & pathologists for diagnosing & monitoring patients with cancer.

Report Coverage	Details
Study Period	Historical Data: 2016-19
	Base Year: 2020
	Forecast Period: 2021-26
CAGR	11.2%
Regions Covered	North America: USA, Canada, Mexico
	Europe: Germany, UK, France, Italy, Spain, Others
	Asia-Pacific: China, India, Japan, South Korea
	South America: Brazil, and Others
	Middle East & Africa: UAE, Saudi Arabia, South Africa
Key Companies Profiled	Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cytognos, S.L., Danaher Corporation, Luminex Corporation, Sony Corporation, Cytek Biosciences
Unit Denominations	USD Million/Billion

The growth of the global flow cytometry in oncology market is likely to be driven primarily by the mounting prevalence of hematological malignancies and rising consumer awareness about precision medicine & tailored therapies. Nearly every 3 minutes, one person in the US gets diagnosed with lymphoma, leukemia, or myeloma. It is estimated that 186,400 people will be diagnosed with lymphoma, leukemia, or myeloma across the US in 2021.

Nevertheless, rapid developments in the field of cancer diagnostics and the burgeoning adoption of flow cytometers by end-users for therapeutic monitoring & conducting cancer diagnosis are other crucial factors projected to drive the global market during 2021-26.

Impact of Covid-19 on the Global Flow Cytometry in Oncology Market

The advent of Covid-19 in 2020 minimally impacted the Global Flow Cytometry in Oncology Market since the industry is entirely research-based. However, manufacturers in the global market witnessed revenue losses in the first two quarters of the fiscal year, 2020-21. Further, temporary halts on research activities associated with flow cytometry and the low influx of cancer patients in hospitals also led to a decline in the market growth.

However, healthcare systems are rapidly reorganizing cancer services to enhance their facilities and ensure that patients receive essential care continuously while minimizing exposure to Covid-19 infection. Hence, the coming years are set to generate remunerative opportunities for the Global Flow Cytometry in Oncology Market.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Segmentation
Executive Summary
Impact of Covid-19 on Flow Cytometry in Oncology Market Analysis
Global Flow Cytometry in Oncology Market Policies & Regulations
Global Flow Cytometry in Oncology Market Trends & Insight
Global Flow Cytometry in Oncology Market Dynamics
1. Impact Analysis
2. Drivers
3. Challenges
Global Flow Cytometry in Oncology Market Hotspot & Opportunities
Global Flow Cytometry in Oncology Market Supply Chain
Global Flow Cytometry in Oncology Market Analysis, 2016-2026
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Type
    1. Assay & Kits
    2. Instruments
    3. Reagents & Consumables
    4. Software
  2. By Technology
    1. Cell Based
    2. Bead Based
  3. By Type of Cancer
    1. Hematological Malignancies
      1. Lymphoma
      2. Leukemia
      3. Myeloma
      4. Others
    2. Solid Tumors
      1. Breast Cancer
      2. Prostate Cancer
      3. Colorectal Cancer
      4. Lung Cancer
      5. Others
  4. By Application
    1. Translational Research
    2. Clinical Applications
      1. Screening & Diagnostics
      2. Treatment Monitoring
  5. By End User
    1. Diagnostic Laboratories
    2. Hospitals and Healthcare Centers
    3. Academic & Research Institutes
    4. Others
  6. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia Pacific
  7. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
    3. Competitor Placement in MarkNtel Quadrant
North America Flow Cytometry in Oncology Market Outlook, 2016-2026
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Type of Cancer
  4. By Application
  5. By End User
  6. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
4. Canada Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
5. Mexico Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
South America Flow Cytometry in Oncology Market Outlook, 2016-2026
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Type of Cancer
  4. By Application
  5. By End User
  6. By Country
    1. Brazil
    2. Others
3. Brazil Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
Europe Flow Cytometry in Oncology Market Outlook, 2016-2026
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Type of Cancer
  4. By Application
  5. By End User
  6. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Others
3. The UK Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
4. Germany Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
5. France Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
6. Italy Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
7. Spain Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
Middle East & Africa Flow Cytometry in Oncology Market Outlook, 2016-2026
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Type of Cancer
  4. By Application
  5. By End User
  6. By Country
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Others
3. Saudi Arabia Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
4. UAE Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
5. South Africa Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
Asia Pacific Flow Cytometry in Oncology Market Outlook, 2016-2026
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Technology
  3. By Type of Cancer
  4. By Application
  5. By End User
  6. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Others
3. China Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
4. India Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
5. Japan Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
6. South Korea Flow Cytometry in Oncology Market Outlook, 2016-2026
  1. Market Size & Analysis
    1. By Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Type of Cancer
Competition Outlook
1. Competition Matrix
  1. Target Markets
  2. Research & Development
  3. Collaborations & Strategic Alliances
  4. Business Restructuring – Mergers, Acquisitions, JVs
  5. Strategic Initiatives
2. Company Profiles (Business Description, Demand Segments, Market Focused Demand Segment, Business Segments, Market Focused Business Segment, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Agilent Technologies, Inc.
  2. Apogee Flow Systems Ltd.
  3. Becton, Dickinson and Company
  4. Bio-Rad Laboratories, Inc.
  5. Bio-Techne Corporation
  6. Cytognos, S.L.
  7. Danaher Corporation
  8. Luminex Corporation
  9. Sony Corporation
  10. Cytek Biosciences
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *

Contact Number *

Your Enquiry Details

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Related Reports

Talk to our Consultant

Customization Offered

Request Customization